Metabolic evaluation of the sick neonate

Cheryl L Garganta1, Wendy E Smith

  • 1Division of Genetics, Department of Pediatrics, Tufts-New England Medical Center, Boston, MA 02111, USA. CGarganta@tufts-nemc.org

Seminars in Perinatology
|August 24, 2005
PubMed

Insights

Early identification of inherited metabolic diseases in newborns is crucial. Common lab tests can signal the need for specialized evaluation, improving outcomes and reducing risks.

Area of Science:

  • Biochemistry
  • Pediatrics
  • Genetics

Background:

  • Inherited metabolic diseases (IMDs) are rare but serious causes of infant illness.
  • These conditions carry significant recurrence risks for families.
  • Timely diagnosis and treatment are vital to prevent severe health issues and developmental delays.

Purpose of the Study:

  • To review common laboratory abnormalities indicative of IMDs.
  • To guide the selection of appropriate specialized metabolic testing.
  • To emphasize the importance of metabolic specialist consultation.

Main Methods:

  • Review of literature on laboratory findings in IMDs.
  • Analysis of how common clinical laboratory tests can flag potential metabolic disorders.
  • Discussion of diagnostic pathways for IMDs.

Main Results:

  • Certain common laboratory test results can suggest the presence of an IMD.
  • These abnormalities serve as crucial indicators for further specialized metabolic investigations.
  • Early recognition facilitates prompt intervention.

Conclusions:

  • Common laboratory tests play a key role in the initial detection of IMDs in neonates.
  • Prompt evaluation and specialized testing guided by initial findings are essential.
  • Collaboration with metabolic specialists ensures optimal patient outcomes.